Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

St Jude Medical received european Approval of ICDs with Features That Automatically Enhance Patient

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

US Speeds Insurance Coverage for Breakthrough...

A new federal initiative in the United States is...

FDA Flags Nitrosamine Impurity Risk in...

The U.S. Food and Drug Administration (FDA), through its...

FDA 510(k) Clearance Granted to Philips...

Philips has secured FDA 510(k) clearance for its Rembra...

St. Jude Medical received european Approval of ICDs  with Features That Automatically Enhance Patient Safety

St. Jude Medical, Inc.announced European CE Mark approval of its AnalyST Accel and Current Accel™ ICDs, which automatically adjust therapy to changing patient needs for increased safety and accelerated follow-up.

The St. Jude Medical Accel family of ICD devices can be programmed to automatically monitor and adjust the level of electrical energy needed for stimulating the patient’s heart, which helps to ensure that adequate therapy is consistently administered while conserving battery life. The devices do this by measuring the heart’s reaction to electrical stimulation from the device and confirming that the heart is responding to the stimulation.

To better assist physicians in accurately diagnosing and managing patients with fast rates in the heart’s upper chambers (atria), the devices also include a new AT/AF Alert feature. This feature is designed to notify physicians when a rapid atrial rate (atrial tachycardia/atrial fibrillation [AT/AF]) exceeds a programmed value or occurs over an extended time period.

 

MEDICAL FAIR ASIA 2026

Latest stories

Related stories

US Speeds Insurance Coverage for Breakthrough Medical Device

A new federal initiative in the United States is...

FDA Flags Nitrosamine Impurity Risk in Combination Products

The U.S. Food and Drug Administration (FDA), through its...

FDA 510(k) Clearance Granted to Philips Rembra Platform

Philips has secured FDA 510(k) clearance for its Rembra...

BVI Virtuoso Receives CE Mark for Dual Eye Surgery System

BVI Medical has secured CE Mark certification under the...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »